Casein kinase II phosphorylates Iκbα at S-283, S-289, S-293, and T-291 and is required for its degradation

Molecular and Cellular Biology

Volumn 16, Issue 3, 1996, Pages 899-906

  Mcelhinny, Julie A ^a   Trushin, Sergey A ^b   Bren, Gary D ^b   Chester, Nicholas ^c   Paya, Carlos V ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Watson School of Biological Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOPROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030022860     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.3.899     Document Type: Article

References (76)

1. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J.-L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes Nature (London) 350:709-712.
2. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217
3. Baeuerle, P. A., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689-1698.
4. Baeuerle, P., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
5. Baeuerle, P. A., and T. Henkel. 1994 Function and activation of NF-κB in the immune system Annu. Rev Immunol 12:141-179.
6. Barroga, C. F., J. K. Stevenson, E. M. Schwarz, and I. M. Verma. 1995. Constitutive phosphorylation of IκBα by casein kinase II Proc. Natl. Acad. Sci USA 92:7637-7641.
7. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism of NF-κB activation. Mol. Cell. Biol. 13:3301-3310.
8. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
9. Boyle, W. J., P. Van Der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149
10. Britta-Mareen Traenckner, E., S. Wilk, and P. A. Baeuerle. 1994 A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433-5441.
11. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
12. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
13. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90:2532-2536.
14. Carroll, D., N. Santoro, and D. Marshak. 1988. Regulating cell growth: casein kinase II-dependent phosphorylation of nuclear oncoproteins. Cold Spring Harbor Symp. Quant. Biol. 53:91-95.
15. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
16. Chen-Wu, J. L., R. Padmanabha, and C. V. Glover. 1988. Isolation, sequencing, and disruption of the CKA1 gene, encoding the alpha subunit of yeast casein kinase II. Mol. Cell. Biol. 8:4981-4990.
17. Chester, N., I. J. Yu, and D. R. Marshak. 1995. Identification and characterization of protein kinase CKII isoforms in HeLa cells. J. Biol. Chem. 270:7501-7514.
18. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993 Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803-11810
19. Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H.-C. Liou, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science 253:1268-1271.
20. Diaz-Meco, M. T., I. Dominguez, L. Sanz, P. Dent, J. Lozano, M. M. Municio, E. Berra, R. T. Hay, T. W. Sturgill, and J. Moscat. 1994. ζPKC induces phosphorylation and inactivation of IκB-α in vitro. EMBO J. 13:2842-2848.
21. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol. 15:1302-1311.
22. Ernst, M. K., L. L. Dunn, and N. R. Rice. 1995. The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or ReLA homodimers Mol. Cell. Biol. 15:872-882.
23. Finco, T. S., A. A. Beg, and A. S. Baldwin, Jr. 1994. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad Sci. USA 91:11884-11888.
24. Firzlaff, J., J. Galloway, R. Eisenman, and B. Luscher. 1989. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biol. 1:44-53.
25. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcincurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861-870.
26. Gartner, S., P. Markovits, D. M. Markovitz, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
27. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature (London) 344:678-682
28. Glineur, C., M. Bailly, and J. Ghysdael. 1989. The c-Erb-A α-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II. Oncogene 4:1247-1254.
29. Grasser, F. A., K. H. Scheidtmann, P. T. Tuazon, J. A. Traugh, and G. Walter. 1988. In vitro phosphorylation of SV40 large T antigen. Virology 165:13-22
30. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
31. Haskill, D., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
32. Hathaway, G. M., T. H. Lubben, and J. A. Traugh. 1980. Inhibition of casein kinase II by heparin J. Biol. Chem. 255:8038-8041.
33. Henkel, T., T. Machleidt, I. Alkalay, M. Krönke, Y. Ben-Neriah, and P. A. Baeuerle. 1993 Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 365:182-185.
34. Herrero, J. A., P. Mathew, and C. V. Paya. 1995 LMP-1 activates NF-κB by targeting the inhibitory molecule IκBα J. Virol. 69:2168-2174
35. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
36. Inoue, J. I., L. D. Kerr, A. Kakizuka, and I. M. Verma. 1992. IκB-gamma, a 70 kD protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109-1120.
37. Kameshita, I., and H. Fujasawa. 1989. A sensitive method tor detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem. 183:139-143.
38. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
39. Lee, C., Y. Yun, J. Hoeffler, and J. Habener. 1990. Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO J. 9:4455-4465
40. Li, S., and J. M. Sedivy. 1993. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc. Natl. Acad. Sci. USA 90:9247-9251.
41. Lin, A., J. Frost, T. Deng, T. Smeal, N. Al-Alawi, U. Kikkawa, T. Hunter, D. Brenner, and M. Karin. 1992. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell 70:777-789.
42. Lin, Y.-C., K. Brown, and U. Siebenlist. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:552-556.
43. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
44. Liou, H.-C., G. P. Nolan, S. Ghosh, T. Fujita, and D. Baltimore. 1992. The NF-κB precursor p105 contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J. 11:3003-3009.
45. Luscher, B., E. Christenson, D. Litchfield, E. Krebs, and R. Eisenman. 1990. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature (London) 344:517-522.
46. Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J 8:1111-1119.
47. Manak, R., N. deBisschop, R. Kris, and R. Prywes. 1990. Casein kinase II enhances the DNA binding activity of serum response factor. Genes Dev. 4:955-967.
48. McElhinny, J. A., W. S. MacMorran, G. D. Bren, R. M. Ten, A. Israel, and C. V. Paya. 1995. Regulation of IκBα and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. J. Virol. 69:1500-1509.
49. Meek, D., S. Simon, U. Kikkawa, and W. Eckhart. 1990. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 9:3253-3260.
50. Meisner, H., and M. P. Czech. 1991. Phosphorylation of transcripdonal factors and cell-cycle-dependent proteins by casein kinase II. Curr. Opin. Cell Biol. 3:474-483.
51. Meisner, H., R. Heller-Harrison, J. Buxton, and M. P. Czech. 1989. Molecular cloning of the human casein kinase II alpha subunit. Biochemistry 28:4072-4076.
52. Meyer, H. E., E. Hoffmann Posorske, H. Korte, and L. M. G. Heilmeyer, Jr. 1986. Sequence analysis of phosphoserine-containing peptides: modification for picomolar sensitivity. FEBS Lett 204:61-66
53. Molinari, M., J. Anagli, and E. Carafoli. 1995. PEST sequences do not influence substrate susceptibility to calpain proteolysis. J. Biol. Chem. 270: 2032-2035.
54. Nolan, G. P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel related polypeptide. Cell 64:961-969.
55. Padmanabha, R., J. L.-P. Chen-Wu, D. E. Hanna, and C. V. C. Glover. 1990. Isolation, sequencing, and disruption of the yeast CKA2 gene casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol Cell. Biol. 10: 4089-4099
56. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
57. Paya, C. V., R. M. Ten, C. Bessia, J. Alcami, R. T. Hay, and J.-L. Virelizier. 1992. NF-κB-dependent induction of the NF-κB p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc. Natl. Acad. Sci. USA 89:7826-7830
58. Pinna, L. A. 1990. Casein kinase 2: an 'eminence grise' in cellular regulation ? Biochim. Biophys. Acta 1054:267-284.
59. Reynolds, C., P. F. Riley, and J. J. Adamson. 1994 Selective precipitation purification procedure for multiple phosphoseryl-containing peptides and methods for their identification Anal. Biochem. 217:277-284.
60. Rice, N. R., and M. K. Ernst. 1994 In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685-4695
61. Rice, N. R., M. L. MacKichan, and A. Israël. 1992. The precursor of NF-κB has IκB-like functions. Cell 71:243-253
62. Rodriguez, M. S., I. Michalopoulos, F. Arenzana-Seisdedos, and R. T. Hay. 1995. Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol 15:2413-2419.
63. Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
64. Roulston, A., M. D'Addario, F. Boulerice, S. Caplan, M. A. Wainberg, and J. Hiscott. 1992. Induction of monocytic differentiation and NF-κB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells J. Exp. Med. 175:751-763
65. Saxena, A., R. Padmanabha, and C. V. Glover. 1987. Isolation and sequencing of cDNA clones encoding alpha and beta subunits of Drosophila melanogaster casein kinase II. Mol Cell. Biol 7:3409-3417.
66. Scheinman, R. I., A. A. Beg, and A. S. Baldwin, Jr. 1993 NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
67. Seldin, D. C., and P. Leder. 1995. Casein kinase IIα transgene-induced marine lymphoma: relation to theiteriosis in cattle. Science 267:894-897.
68. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716.
69. Shirakawa, F., and S. B. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424-2430.
70. Simek, S., and N. R. Rice. 1988. Detection and characterization of the protein encoded by the chicken c-rel protooncogene. Oncogene Res. 2:103-119
71. Sun, S.-C., J. Elwood, C. Beraud, and W. C. Greene. 1994. Human T-cell leukemia type I virus Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377-7384
72. Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκB α: evidence for an inducible autoregulatory pathway. Science 259:1912-1915
73. Sun, S.-C., P. A. Ganchi, C. Beraud, D. W. Ballard, and W. C. Greene. 1994 Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA 91:1346-1350.
74. Traenckner, E. B.-M., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli EMBO J. 14:2876-2883.
75. Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israël. 1995. N- and C-terminal sequences control degradation of MAD3 IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15:5339-5345.
76. Zabel, U., and P. A. Baeuerle. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA Cell 61:255-265.